Silencing soluble epoxide hydrolase protects against myocardial ischemia–reperfusion injury through modulation of the YAP signaling pathway and macrophage polarization

Algoet M et al (2023) Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc Med 33:357–366. https://doi.org/10.1016/j.tcm.2022.02.005

Article  PubMed  CAS  Google Scholar 

Cheng X et al (2024) Glycyrrhizic acid alleviated MI/R-induced injuries by inhibiting Hippo/YAP signaling pathways. Cell Signal 115:111036. https://doi.org/10.1016/j.cellsig.2024.111036

Article  PubMed  CAS  Google Scholar 

Das Mahapatra A, Choubey R, Datta B (2020) Small molecule soluble epoxide hydrolase inhibitors in multitarget and combination therapies for inflammation and cancer. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules25235488

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Theken KN, Lee CR (2010) Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J Mol Cell Cardiol 48:331–341. https://doi.org/10.1016/j.yjmcc.2009.10.022

Article  PubMed  CAS  Google Scholar 

Fan Q et al (2019) Dectin-1 contributes to myocardial ischemia/reperfusion injury by regulating macrophage polarization and neutrophil infiltration. Circulation 139:663–678. https://doi.org/10.1161/circulationaha.118.036044

Article  PubMed  CAS  Google Scholar 

Funk DJ, Sorg BL, Kopka K, Schmeiser HH (2016) Epoxyeicosatrienoic acids (EETs) form adducts with DNA in vitro. Prostagl Other Lipid Med 123:63–67. https://doi.org/10.1016/j.prostaglandins.2016.04.006

Article  CAS  Google Scholar 

Goldsborough E 3rd, Osuji N, Blaha MJ (2022) Assessment of cardiovascular disease risk: a 2022 update. Endocrinol Metab Clin North Am 51(3):483–509. https://doi.org/10.1016/j.ecl.2022.02.005

Article  PubMed  Google Scholar 

Hoole SP, Bambrough P (2020) Recent advances in percutaneous coronary intervention. Heart (British Cardiac Society) 106:1380–1386. https://doi.org/10.1136/heartjnl-2019-315707

Article  PubMed  CAS  Google Scholar 

Huang H, Weng J, Wang MH (2016) EETs/sEH in diabetes and obesity-induced cardiovascular diseases. Prostagl Other Lipid Mediat 125:80–89. https://doi.org/10.1016/j.prostaglandins.2016.05.004

Article  CAS  Google Scholar 

Huang X et al (2018) Ophiopogonin D reduces myocardial ischemia-reperfusion injury via upregulating CYP2J3/EETs in rats. Cell Physiol Biochem 49:1646–1658. https://doi.org/10.1159/000493500

Article  PubMed  CAS  Google Scholar 

Kakavand H, Aghakouchakzadeh M, Coons JC, Talasaz AH (2021) Pharmacologic prevention of myocardial ischemia-reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. J Cardiovas Pharmacol 77:430–449. https://doi.org/10.1097/fjc.0000000000000980

Article  CAS  Google Scholar 

Kapur NK, Thayer KL, Zweck E (2020) Cardiogenic shock in the setting of acute myocardial infarction. Methodist DeBakey Cardiovas J 16:16–21. https://doi.org/10.14797/mdcj-16-1-16

Article  Google Scholar 

Kim SJ, Mesquita FCP, Hochman-Mendez C (2023) neW biomarkers for cardiovascular disease. Texas Heart Instit J. https://doi.org/10.14503/thij-23-8178

Article  Google Scholar 

Lan M et al (2022) Cardiomyocyte-targeted anti-inflammatory nanotherapeutics against myocardial ischemia reperfusion (IR) injury. Nano Res 15:9125–9134. https://doi.org/10.1007/s12274-022-4553-6

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu YC, Zou XB, Chai YF, Yao YM (2014) Macrophage polarization in inflammatory diseases. Int J Biol Sci 10:520–529. https://doi.org/10.7150/ijbs.8879

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu T, Guo X, Fu Y, Zhang W (2025) SLAMF9 aggravates myocardial ischemia reperfusion injury through activating the Hippo-YAP pathway. Biochim Biophys Acta Gen Subj 1869:130821. https://doi.org/10.1016/j.bbagen.2025.130821

Article  PubMed  CAS  Google Scholar 

Matsuda T et al (2016) NF2 Activates Hippo signaling and promotes ischemia/reperfusion injury in the heart. Circ Res 119:596–606. https://doi.org/10.1161/circresaha.116.308586

Article  PubMed  PubMed Central  CAS  Google Scholar 

Niu J et al (2020) Cardioprotective effect of Echinatin against ischemia/reperfusion injury: Involvement of Hippo/Yes-Associated Protein signaling. Front Pharmacol 11:593225. https://doi.org/10.3389/fphar.2020.593225

Article  PubMed  CAS  Google Scholar 

Saito Y, Oyama K, Tsujita K, Yasuda S, Kobayashi Y (2023) Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond. J Cardiol 81:168–178. https://doi.org/10.1016/j.jjcc.2022.07.003

Article  PubMed  Google Scholar 

Shapouri-Moghaddam A et al (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233:6425–6440. https://doi.org/10.1002/jcp.26429

Article  PubMed  CAS  Google Scholar 

Spector AA, Fang X, Snyder GD, Weintraub NL (2004) Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43:55–90. https://doi.org/10.1016/s0163-7827(03)00049-3

Article  PubMed  CAS  Google Scholar 

Spiecker M, Liao JK (2005) Vascular protective effects of Cytochrome P450 epoxygenase-derived eicosanoids. Arch Biochem Biophys 433:413–420. https://doi.org/10.1016/j.abb.2004.10.009

Article  PubMed  CAS  Google Scholar 

Vogel B et al (2021) The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet (London, England) 397:2385–2438. https://doi.org/10.1016/s0140-6736(21)00684-x

Article  PubMed  Google Scholar 

Wang Y, Ding J, Song H (2022) VSIG4 regulates macrophages polarization and alleviates inflammation through activating PI3K/AKT and inhibiting TLR4/NF-κB pathway in myocardial ischemia-reperfusion injury rats. Physiol Int. https://doi.org/10.1556/2060.2022.00055

Article  PubMed  Google Scholar 

Wu H et al (2024) The multifaceted roles of Hippo-YAP in cardiovascular diseases. Cardiovasc Toxicol 24:1410–1427. https://doi.org/10.1007/s12012-024-09926-6

Article  PubMed  CAS  Google Scholar 

Xiang Q, Yi X, Zhu XH, Wei X, Jiang DS (2024) Regulated cell death in myocardial ischemia-reperfusion injury. Trends Endocrinol Metabol TEM 35:219–234. https://doi.org/10.1016/j.tem.2023.10.010

Article  CAS  Google Scholar 

Xu S, Tao D (2022) Leptin alleviates inflammatory response in myocardial ischemia reperfusion injury. Dis Mark 2022:8707061. https://doi.org/10.1155/2022/8707061

Article  CAS  Google Scholar 

Yang C et al (2020) Neuroprotective effect of Catalpol via anti-oxidative, anti-inflammatory, and anti-apoptotic mechanisms. Front Pharmacol 11:690. https://doi.org/10.3389/fphar.2020.00690

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yu H et al (2021) RRM2 Improves cardiomyocyte proliferation after myocardial ischemia reperfusion injury through the Hippo-YAP pathway. Dis Markers 2021:5089872. https://doi.org/10.1155/2021/5089872

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yunna C, Mengru H, Lei W, Weidong C (2020) Macrophage M1/M2 polarization. Eur J Pharmacol 877:173090. https://doi.org/10.1016/j.ejphar.2020.173090

Article  PubMed  CAS 

Comments (0)

No login
gif